Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jun-Kyu Lee has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Hak Cheol Kwon

    Natural Product Informatics Research Center, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea

    1 shared publication
  • InWha Park

    School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea

    1 shared publication
  • Jaeyoung Kwon

    KIST Gangneung Institute of Natural Products, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea; Natural Product Applied Science, University of Science and Technology (UST), Daejeon 34113, Republic of Korea; Department of Convergence Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea

    1 shared publication
  • Ji-Wan Choi

    Department of Life Science, Gachon University, Seongnam 13120, Republic of Korea

    1 shared publication
  • Na-Eun Kim

    Department of Life Science, Gachon University, Seongnam 13120, Republic of Korea

    1 shared publication
  • Yoon-Jae Song

    Department of Life Science, Gachon University, Seongnam 13120, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Roseoside Is a Bioactive Compound in Kirengeshoma koreana Nakai Extract with Potent In Vitro Antiviral Activity Against Hepatitis C Virus

    by Jun-Kyu Lee, Ji-Wan Choi, InWha Park, Na-Eun Kim, Hak Cheol Kwon, Jaeyoung Kwon, Yoon-Jae Song

    Hepatitis C virus (HCV) is a pathogen that causes cirrhosis and hepatocellular carcinoma through chronic hepatitis C. This study focused on the anti-HCV activity of a 70% ethanol extract of Kirengeshoma koreana Nakai (KKE) and its bioactive chemical constituent(s). The KKE and its n-butanol (n-BuOH) fraction induced a significant reduction in HCV RNA levels without inducing cytotoxicity. A high-performance liquid chromatography–mass spectrometry (HPLC-MS) analysis revealed the presence of roseoside in the n-butanol fraction of the KKE, which inhibited HCV RNA replication in a concentration- and time-dependent manner without exerting cytotoxicity. Consistent with in silico molecular docking analysis data, roseoside targets and inhibits HCV NS5A/B replicase. Collectively, our findings demonstrate that roseoside is a chemical constituent in KKE that interferes with HCV replication by targeting NS5A/B replicase.